Condition
Glioblastoma|Renal Cell Carcinoma|Sarcomas|Breast Cancers|Malignant Mesothelioma|Colorectal Tumors
Estimated Enrollment: 10
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: CCRG 11-001
Study First Received: February 7, 2011
Last Updated: July 11, 2013
Estimated Primary Completion Date: February 2014
Primary Outcome Measures:
Immunogenicity of intradermal DC vaccination
Sponsors and Collaborators:
University Hospital, Antwerp
Website Link: https://ClinicalTrials.gov/show/NCT01291420
